Accenture and Tokyo Women's Medical University to Conduct Joint Research on Potential Benefits of Artificial Intelligence for Kidney Transplant Treatment
TOKYO; Nov. 5, 2020 – Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients.
from News | Accenture Newsroom https://ift.tt/2TVeAvi
from News | Accenture Newsroom https://ift.tt/2TVeAvi
Comments
Post a Comment